Gregory Divis | Chief Executive Officer |
Jennifer Gudeman | Vice President of Medical & Clinical Affairs |
Richard Kim | Chief Commercial Officer |
Tom McHugh | Senior Vice President & Chief Financial Officer |
Francois Brisebois | Oppenheimer |
Ami Fadia | Needham |
Chris Howerton | Jefferies |
Adam Evertts | LifeSci Capital |
Marc Goodman | SVB |
Matt Kaplan | Ladenburg Thalmann |
Chase Knickerbocker | Craig Hallum |
Good morning. My name is Rob and I will be your conference operator today. At this time I would like to welcome everyone to the Avadel Pharmaceuticals' Third Quarter 2022 Earnings Call. [Operator Instructions] Thank you. Austin Morton [ph] from Avadel Investor Relations.